FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2392016048> ?p ?o ?g. }

• W2392016048 endingPage "725" @default.
• W2392016048 startingPage "725" @default.
• W2392016048 abstract "The nucleotide-binding domain, leucine-rich repeat/pyrin domain-containing-3 (NALP3) inflammasome, which is required for synthesis of interleukin-1β, has been implicated in the pathogenesis of several autoinflammatory syndromes. This review of the literature summarizes the interconnectedness of NALP3 inflammasome with some of these disorders. Familial Mediterranean fever results from a mutation in the Mediterranean fever (MEFV) gene, which encodes the pyrin protein. Previous study results suggest that pyrin suppresses caspase-1 activation, perhaps by competing for the adaptor protein, termed, pyrin domain of apoptosis/speck-like protein containing a caspase-recruitment domain (ACS) which therefore interferes with NALP3 inflammasome activation. The nucleotide-binding domain, leucine-rich repeat/pyrin domain-containing-3 (NALP3) inflammasome is constitutively activated in cryopyrin-associated periodic syndromes due to gain-of-function mutations resulting from point mutations within the neuronal apoptosis inhibitor protein/class 2 transcription factor/heterokaryon incompatibility/telomerase-associated protein-1 (NACHT) domain of the NALP3 protein. Pyogenic arthritis, pyoderma gangrenosum and acne (PAPA) syndrome is caused by mutations in the genes encoding proline-serine-threonine phosphatase interacting protein 1 (PSTPIP1). These PSTPIP1 mutants are thought to bind to pyrin causing an increase in the pyrin domain of apoptosis/speck-like protein containing a caspase-recruitment domain (ASC) pyroptosome assembly leading to procaspase-1 recruitment and therefore its activation. Hyperimmunoglublinemia D syndrome is caused by mevalonate kinase (MVK) deficiency, which may be affected by protein accumulation that leads to NALP3 inflammasome activation. Tumor necrosis factor receptor–associated periodic syndrome is associated with mutations in the tumor necrosis factor receptor superfamily, member 1A (TNFRSF1A) gene which decreases the level of soluble tumor necrosis factor receptor-1 (TNFR1) leading to neutralization of tumor necrosis factor (TNF)-α. In general, these autoinflammatory disorders have shown a clinical response to interleukin-1 (IL-1) antagonists, suggesting that the NALP3 inflammasome serves a critical role in their pathogenesis." @default.
• W2392016048 created "2016-06-24" @default.
• W2392016048 creator A5000958306 @default.
• W2392016048 creator A5037419784 @default.
• W2392016048 creator A5063951626 @default.
• W2392016048 creator A5088893063 @default.
• W2392016048 date "2016-05-13" @default.
• W2392016048 modified "2023-10-16" @default.
• W2392016048 title "The Relationship between NALP3 and Autoinflammatory Syndromes" @default.
• W2392016048 cites W144760583 @default.
• W2392016048 cites W1487398031 @default.
• W2392016048 cites W1560867514 @default.
• W2392016048 cites W1754287932 @default.
• W2392016048 cites W1885912605 @default.
• W2392016048 cites W1950464121 @default.
• W2392016048 cites W1964535559 @default.
• W2392016048 cites W1971915082 @default.
• W2392016048 cites W1973333409 @default.
• W2392016048 cites W1974781808 @default.
• W2392016048 cites W1978008054 @default.
• W2392016048 cites W1992373415 @default.
• W2392016048 cites W1993976394 @default.
• W2392016048 cites W1998410934 @default.
• W2392016048 cites W1998960894 @default.
• W2392016048 cites W1999331329 @default.
• W2392016048 cites W2002466168 @default.
• W2392016048 cites W2005477006 @default.
• W2392016048 cites W2014359667 @default.
• W2392016048 cites W2018915861 @default.
• W2392016048 cites W2020908160 @default.
• W2392016048 cites W2033023137 @default.
• W2392016048 cites W2036710606 @default.
• W2392016048 cites W2058243697 @default.
• W2392016048 cites W2061454272 @default.
• W2392016048 cites W2062946728 @default.
• W2392016048 cites W2077808351 @default.
• W2392016048 cites W2083062923 @default.
• W2392016048 cites W2086655991 @default.
• W2392016048 cites W2092360953 @default.
• W2392016048 cites W2095393210 @default.
• W2392016048 cites W2097901599 @default.
• W2392016048 cites W2099243390 @default.
• W2392016048 cites W2099808663 @default.
• W2392016048 cites W2102429140 @default.
• W2392016048 cites W2102498884 @default.
• W2392016048 cites W2102694854 @default.
• W2392016048 cites W2105155669 @default.
• W2392016048 cites W2105405561 @default.
• W2392016048 cites W2109307284 @default.
• W2392016048 cites W2111898139 @default.
• W2392016048 cites W2114227513 @default.
• W2392016048 cites W2114769428 @default.
• W2392016048 cites W2115842856 @default.
• W2392016048 cites W2122287804 @default.
• W2392016048 cites W2122708413 @default.
• W2392016048 cites W2128190429 @default.
• W2392016048 cites W2128464705 @default.
• W2392016048 cites W2134735862 @default.
• W2392016048 cites W2146336227 @default.
• W2392016048 cites W2147388894 @default.
• W2392016048 cites W2149589224 @default.
• W2392016048 cites W2165275387 @default.
• W2392016048 cites W2166973746 @default.
• W2392016048 cites W2171241497 @default.
• W2392016048 cites W2242165656 @default.
• W2392016048 cites W2254807163 @default.
• W2392016048 cites W270322905 @default.
• W2392016048 cites W4210660926 @default.
• W2392016048 cites W4231171153 @default.
• W2392016048 cites W4242693087 @default.
• W2392016048 cites W55729810 @default.
• W2392016048 cites W79960063 @default.
• W2392016048 doi "https://doi.org/10.3390/ijms17050725" @default.
• W2392016048 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4881547" @default.
• W2392016048 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27187378" @default.
• W2392016048 hasPublicationYear "2016" @default.
• W2392016048 type Work @default.
• W2392016048 sameAs 2392016048 @default.
• W2392016048 citedByCount "34" @default.
• W2392016048 countsByYear W23920160482016 @default.
• W2392016048 countsByYear W23920160482017 @default.
• W2392016048 countsByYear W23920160482018 @default.
• W2392016048 countsByYear W23920160482019 @default.
• W2392016048 countsByYear W23920160482020 @default.
• W2392016048 countsByYear W23920160482021 @default.
• W2392016048 countsByYear W23920160482022 @default.
• W2392016048 countsByYear W23920160482023 @default.
• W2392016048 crossrefType "journal-article" @default.
• W2392016048 hasAuthorship W2392016048A5000958306 @default.
• W2392016048 hasAuthorship W2392016048A5037419784 @default.
• W2392016048 hasAuthorship W2392016048A5063951626 @default.
• W2392016048 hasAuthorship W2392016048A5088893063 @default.
• W2392016048 hasBestOaLocation W23920160481 @default.
• W2392016048 hasConcept C104317684 @default.
• W2392016048 hasConcept C126322002 @default.
• W2392016048 hasConcept C139174496 @default.
• W2392016048 hasConcept C139964883 @default.
• W2392016048 hasConcept C162157009 @default.

• next